These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30442330)

  • 1. Regulation of immune responses by E3 ubiquitin ligase Cbl-b.
    Tang R; Langdon WY; Zhang J
    Cell Immunol; 2019 Jun; 340():103878. PubMed ID: 30442330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
    Liu Q; Zhou H; Langdon WY; Zhang J
    Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
    Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
    J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
    Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
    J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
    Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
    Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
    Loeser S; Penninger JM
    Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.
    Jafari D; Mousavi MJ; Keshavarz Shahbaz S; Jafarzadeh L; Tahmasebi S; Spoor J; Esmaeilzadeh A
    Clin Exp Immunol; 2021 Apr; 204(1):14-31. PubMed ID: 33306199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunity.
    Zhu LL; Luo TM; Xu X; Guo YH; Zhao XQ; Wang TT; Tang B; Jiang YY; Xu JF; Lin X; Jia XM
    J Exp Med; 2016 Jul; 213(8):1555-70. PubMed ID: 27432944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
    Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
    Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin E3 ligase Cbl-b in T cells tolerance and tumor immunity.
    Loeser S; Penninger JM
    Cell Cycle; 2007 Oct; 6(20):2478-85. PubMed ID: 17704644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
    Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
    J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and platelets: Mutual interference in the immune network.
    Speth C; Rambach G; Würzner R; Lass-Flörl C; Kozarcanin H; Hamad OA; Nilsson B; Ekdahl KN
    Mol Immunol; 2015 Sep; 67(1):108-18. PubMed ID: 25886718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro.
    Zhou SK; Chen WH; Shi ZD; Wang SP; Li L; Wen XF; Wang YM
    J Chin Med Assoc; 2014 Dec; 77(12):630-6. PubMed ID: 25249301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of targeting IL-17.
    Jones SA; Sutton CE; Cua D; Mills KH
    Nat Immunol; 2012 Nov; 13(11):1022-5. PubMed ID: 23080193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
    Fujiwara M; Anstadt EJ; Khanna KM; Clark RB
    Clin Immunol; 2015 May; 158(1):103-13. PubMed ID: 25829233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.
    Balachandran P; Dragone L; Garrity-Ryan L; Lemus A; Weiss A; Engel J
    J Clin Invest; 2007 Feb; 117(2):419-27. PubMed ID: 17235393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cbl and Cbl-b in T-cell regulation.
    Liu YC; Gu H
    Trends Immunol; 2002 Mar; 23(3):140-3. PubMed ID: 11864842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection.
    Ou R; Zhang M; Huang L; Moskophidis D
    J Virol; 2008 Apr; 82(7):3353-68. PubMed ID: 18199651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
    Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
    J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB downregulates Cbl-b through binding and suppressing Cbl-b promoter in T cell activation.
    Liu Y; Li Y; Zhang L; Li M; Li C; Xue C; Huang X; Zhou P
    J Immunol; 2015 Apr; 194(8):3778-83. PubMed ID: 25762784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.